Thoughts
An examination of innovation and patenting in previous crises has identified some consistent trends and here we look at whether we can extrapolate these to the aftermath of the coronavirus pandemic, both from a technological and from a systemic perspective.
We have seen that patenting activity naturally levels during crises which affect subsistence or economy, though against a background of robust long-term growth.
In this time of extraordinary change and uncertainty, reaction has been rapid, well-meaning and often effective at the individual, enterprise and nationwide level.
Brexit
A recent referral from a UK court to the Court of Justice of the European Union (CJEU) seeks to clarify if disclosure of a design outside the EU may impact the protection conferred to the design in th...
News
The EPO’s recent Enlarged Board of Appeal hearing on patentability of computer simulations was important not only for its legal ramifications. The participants were present, but for the first time eve...
We have all had to adapt in the past few months, as we have become used to widespread lockdowns, home working and reliance on technology rather than face-to-face contact.
For many years, many professional services organisations were afraid of allowing people to work at home. As an HR person I heard that all the time.
An examination of innovation and patenting in previous crises has identified some consistent trends and here we look at whether we can extrapolate these to the aftermath of the coronavirus pandemic, b...
Case law
This article reviews the main findings of Lord Justice Arnold in Akebia v FibroGen, a “clearing the way” patent dispute that raises important questions of UK patent law in relation to Biogen insuffici...
Tomorrow, we will be following and tweeting live updates on the Enlarged Board hearing for simulation-type inventions. The hearing itself will be virtual (not simulated) and open to the public.
Whether working in the corporate or law firm environment, trademark practice leaders should ensure that they have a considered wellbeing strategy in place
Updates
Crystal clear? Patenting polymorphs in Europe. Polymorphs of drug compounds can have significant commercial value. However, obtaining patents for polymorphs at the EPO can be challenging. Here are s...
Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept